Privia Health Group, Inc. $PRVA Shares Purchased by Future Fund LLC

Future Fund LLC boosted its holdings in Privia Health Group, Inc. (NASDAQ:PRVA) by 48.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 65,538 shares of the company’s stock after acquiring an additional 21,247 shares during the quarter. Future Fund LLC’s holdings in Privia Health Group were worth $1,348,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the business. Financiere des Professionnels Fonds d investissement inc. acquired a new position in shares of Privia Health Group during the 1st quarter worth $229,000. Advisors Preferred LLC purchased a new position in shares of Privia Health Group in the 1st quarter valued at about $1,696,000. Fifth Third Bancorp lifted its stake in shares of Privia Health Group by 1,047.1% in the first quarter. Fifth Third Bancorp now owns 38,142 shares of the company’s stock valued at $785,000 after purchasing an additional 34,817 shares during the period. Fort Washington Investment Advisors Inc. OH acquired a new stake in shares of Privia Health Group in the first quarter valued at about $3,900,000. Finally, Pictet Asset Management Holding SA boosted its holdings in Privia Health Group by 15.3% during the first quarter. Pictet Asset Management Holding SA now owns 16,076 shares of the company’s stock worth $331,000 after buying an additional 2,132 shares in the last quarter. Institutional investors and hedge funds own 94.48% of the company’s stock.

Insider Buying and Selling at Privia Health Group

In related news, Director Matthew Shawn Morris sold 53,722 shares of Privia Health Group stock in a transaction that occurred on Monday, July 6th. The stock was sold at an average price of $27.24, for a total transaction of $1,463,387.28. Following the completion of the transaction, the director directly owned 68,188 shares in the company, valued at $1,857,441.12. The trade was a 44.07% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO David Mountcastle sold 21,275 shares of the company’s stock in a transaction that occurred on Thursday, July 9th. The shares were sold at an average price of $27.67, for a total value of $588,679.25. Following the completion of the sale, the chief financial officer directly owned 164,853 shares in the company, valued at approximately $4,561,482.51. The trade was a 11.43% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 478,855 shares of company stock valued at $12,099,109 over the last quarter. Corporate insiders own 5.70% of the company’s stock.

Analyst Ratings Changes

Several research analysts have weighed in on the stock. Weiss Ratings upgraded shares of Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, July 2nd. Evercore set a $26.00 price target on shares of Privia Health Group in a research report on Wednesday, April 8th. Barclays lowered their price target on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 26th. Canaccord Genuity Group dropped their price objective on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a research note on Friday, May 8th. Finally, Zacks Research cut Privia Health Group from a “hold” rating to a “strong sell” rating in a report on Tuesday, July 7th. Eleven research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Privia Health Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $31.15.

Privia Health Group Trading Down 1.2%

Shares of NASDAQ PRVA opened at $26.90 on Friday. The company’s 50-day moving average price is $24.12 and its 200 day moving average price is $23.27. Privia Health Group, Inc. has a 52 week low of $18.77 and a 52 week high of $28.82. The stock has a market cap of $3.39 billion, a price-to-earnings ratio of 168.14, a PEG ratio of 2.15 and a beta of 0.83.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.